Regulatory Information Management Software: Build vs Buy
Buy, and buy Veeva Vault RIM if your regulatory documents already sit in Vault. That covers most companies reading this.
On this page
Buy, and buy Veeva Vault RIM if your regulatory documents already sit in Vault. That covers most companies reading this. Building becomes the better answer when your portfolio mixes medicines, devices and combination products so no vendor hierarchy can hold it, when an implementation has already stalled on data modelling, or when change impact analysis is the capability you actually need.
What the off-the-shelf products actually do well
A manufacturing site proposes changing the supplier of an excipient and asks which registrations it affects. A week later you have a list assembled by email from market leads, two of whom answered from memory. That is the problem you are trying to buy your way out of, and for most companies buying is the right answer.
Veeva Vault RIM is the centre of gravity in this category and it deserves to be. Registrations and the documents that support them live in one place, which is a structural advantage no build reproduces cheaply. ArisGlobal LifeSphere RIMS and Ennov RIM are credible alternatives with real depth. Acolad, formerly Amplexor, has genuine strength in regulatory content. Lorenz docuBridge and Extedo handle electronic Common Technical Document (eCTD) publishing well and neither is worth rebuilding under any circumstances.
These products also carry the standards work you would otherwise fund yourself. eCTD version 4.0 is arriving on different timetables in different regions. The European Medicines Agency runs Substance, Product, Organisation and Referential (SPOR) data services, and the Article 57 obligation to maintain product data in the extended EudraVigilance medicinal product dictionary is a maintenance burden a vendor absorbs. Keeping pace with that on your own budget is not a good use of capital.
So the honest default is buy. If you hold registrations in a handful of markets for a small portfolio and a well governed spreadsheet answers the standing questions, do not even do that. The spreadsheet is proportionate and the money belongs in regulatory headcount.
Where they stop: your product hierarchy is not their product hierarchy
A regulatory information management system is roughly ninety percent data model and ten percent screens, and the model has to match your reality. What counts as a product here? The brand, the medicinal product as a given market defines it, the presentation, the pack, the formulation, or all of them in a hierarchy. Which of those does a licence attach to? How do you represent one formulation sold at a different strength under a different name in three markets?
Every packaged system arrives with an opinionated answer. Implementation is largely the work of forcing your reality into it, and that is where the calendar and the budget go. Companies with a mixed estate of medicines, devices under the European Union Medical Device Regulation with their own Unique Device Identification and EUDAMED obligations, and combination products, are the ones who find the seams.
The second gap is change impact analysis, which is the capability everybody asks for and almost nobody gets. Here is the specific reason. One supplier change is a Type IB variation under Commission Regulation (EC) No 1234/2008 in the European Union, a changes being effected in 30 days supplement under 21 CFR 314.70 in the United States, and in a third market a full prior approval that requires a legalised Certificate of Pharmaceutical Product. The certificate takes weeks to obtain and the apostille takes weeks more. The binding constraint on your implementation date is a document from a foreign ministry, not the dossier. No product knows that unless your registrations record what was actually approved at that level of detail, and most companies have never captured it.
The arithmetic: named user licences versus a build at your market count
Use your own quote. Vendor pricing in this category is generally per named user with a floor, so take the per seat figure, call it S, and count the people who need write access. Regulatory operations, publishing, the market leads who maintain their own registrations, labelling, and the change control assessors. Call that N.
Now count the people who only need to read: manufacturing, quality, supply chain planners, commercial teams asking whether a market is open. In most companies that second group is three to five times the first, and it is precisely the group whose questions started this project. Paying a named user fee so a planner can check a renewal date is the point at which the model stops working.
The crossover sits at roughly 30 to 40 named write users, or 25 to 40 markets with registrations you actively maintain, whichever you reach first. Below that, buy. Above it, the licence line becomes a permanent operating cost that a build converts to a one time cost plus support, and read access stops being a budget decision.
Then add the number that usually settles it. Time the excipient question honestly. If a routine change impact assessment consumes twenty person hours across regulatory affairs and you run forty of them a year, that is a role, and it is not on any licence invoice.
What a custom build actually costs
From Digital Heroes delivery experience, a first release covering the product, medicinal product, presentation and licence hierarchy, registration status, and variation and renewal tracking runs $130,000 to $280,000 and ships in 16 to 24 weeks. A full platform adding health authority commitments, labelling version control, change impact analysis and submission planning runs $350,000 to $900,000 phased across 12 to 22 months.
Data migration adds 10 to 25 percent and in this category it reliably lands at the ceiling, because the information you need sits inside approved dossiers, cover letters and approval documents accumulated over decades. Extracting registered detail is manual work done by people who understand regulatory content, and for a portfolio of any size it is measured in person months. A quotation with no explicit line for data collection has priced the easy half.
Year two runs 15 to 20 percent of build cost annually. Markets amend their variation classifications, a new labelling obligation appears, and the European electronic product information programme keeps moving.
What pushes cost up: the number of markets and how far their frameworks diverge, document management integration, the number of legal entities and licence holders you operate through, and whether you need to produce data aligned to the ISO Identification of Medicinal Products standards. What keeps it down: top markets by revenue first, current registrations rather than full history, and one agreed granularity for registered detail.
The four situations where building wins
- Regulatory fit. If your obligations include device Unique Device Identification and EUDAMED alongside medicinal product data for SPOR, you are maintaining two identity regimes for products that share a bill of materials. Vendor models generally pick one world and treat the other as an attachment, and combination products fall between them.
- Scale economics. Read access demanded by manufacturing, quality and planning while your licence is priced per named user. Once the audience for the answer is larger than the population that maintains it, per seat pricing is working against the purpose of the system.
- A workflow that is your competitive advantage. Companies who win on speed to market in a specific region do it by running variation planning backwards from the deadline through the lead time of every dependent artefact, including certificates and legalisations. If that sequencing is genuinely yours, do not hand it to a configuration screen.
- Integration sprawl across three or more systems. Registrations, a document management system, an enterprise resource planning (ERP) system holding sites and specifications, a labelling and artwork system, and a quality management system carrying change controls. Every pair is a manual reconciliation, and the excipient question crosses all five.
One of these is a vendor conversation. Two of them is a build.
How to decide in a week
Run the change impact drill. Five days, no software, and it produces the only number that matters here.
Monday: pick a real change already in your quality system. A site addition, a specification tightening, a supplier switch. Write down the question precisely: which licences does this touch and what regulatory action does each market require before implementation.
Tuesday and Wednesday: answer it the way you answer it today. Log every email sent, every person asked, every hour spent, and every market where the answer came from memory rather than from a record.
Thursday: check the answers. For three markets, open the actual approval documentation and confirm that what you were told matches what was registered. Count the discrepancies. This is the uncomfortable day and it is the one that decides the business case.
Friday: multiply the hours by the number of changes you assess in a year, then add the cost of one implementation done in a market that needed prior approval. If the drill took under a day and the three checks matched, buy the product, or keep the spreadsheet, and spend the money on regulatory staff. If two of the three did not match, your registered detail is the problem and no purchase fixes it.
What comes next is a paid discovery phase rather than a proposal. Two to three weeks, fixed fee, ending in a signed product requirements document covering the product and licence hierarchy modelled against your most awkward product, the granularity of registered detail, the data collection plan and acceptance criteria. You own that specification whoever builds it.
Who we are wrong for: single market companies, anyone wanting an eCTD publishing tool rebuilt, and anyone who wants code before the hierarchy is agreed on a whiteboard. Digital Heroes writes that document before any code, with more than fifty specialists and India LLP, US LLC and UK LTD entities so intellectual property assigns under your own law. ShopScore, HeroCheckout and Section Vault are our own products, over 2,000 projects sit behind us, and you meet the named team before signing. We are listed on Clutch, Trustpilot, Fiverr Vetted Pro and D-U-N-S.
Book a 30-minute call with Digital Heroes and get a written plan and a fixed quote within 48 hours.
The evidence behind this guide
Independent findings on why this investment pays off. Every link goes to the primary source.
- Large companies globally have captured, on average, only 31% of the expected revenue lift and 25% of the expected cost savings from their digital and AI transformations - a significant gap between expected and realized value. Source: McKinsey & Company (2023) →
- Poor software quality cost the US economy an estimated $2.41 trillion in 2022, including roughly $1.52 trillion in accumulated technical debt, driven partly by unsuccessful development projects and low-quality legacy systems. Source: Consortium for Information & Software Quality (CISQ) - Herb Krasner (2022) →
- An analysis of enrollment and completion data for 221 MOOCs (Katy Jordan, published in the International Review of Research in Open and Distributed Learning, IRRODL, 16(3), 2015 - not the Journal of Distance Education) found completion rates ranging from 0.7% to 52.1%, with a median completion rate of 12.6%, and completion negatively correlated with course length (longer courses had lower completion rates) - underscoring how unsupported self-paced online courses struggle to finish learners. Source: Journal of Distance Education (via ERIC / Katharina Jordan) (2015) →
- Grand View Research valued the global field service management market at USD 4.43 billion in 2022 and projects it to reach USD 11.78 billion by 2030, a 13.3% CAGR, driven by growing field operations in telecom, utilities, construction and energy. Source: Grand View Research (2023) →
Frequently asked questions
How long does a regulatory information management build take?
Sixteen to twenty four weeks for a first release covering the product and licence hierarchy, registration status and variation and renewal tracking. The programme timeline is set by data collection rather than engineering, because registered detail has to be extracted from legacy dossiers by people who understand regulatory content. Companies starting with top markets by revenue and current registrations only reach a usable system considerably sooner.
Who owns the registration data if an agency builds the system?
You should own the repository, the database, the cloud accounts and an agreed export format for the registration data itself, settled in writing before kickoff. At Digital Heroes the client owns the code from the first commit. Registration records outlive any particular system, and you will migrate them again within a decade, so the export format matters as much as the code ownership.
Can we keep Veeva Vault and build only the impact analysis layer?
Frequently that is the right shape. Keep Vault for documents and submissions, since the link between a licence and its approval letter is genuine value, and build the registered detail model and impact analysis above it. The caution is that impact analysis is only as good as the granularity of what you captured, so the build begins with a data collection plan rather than with screens.
What happens if a market changes its variation classification after go live?
It should be a configuration change made by a regulatory affairs professional, not a development ticket. Market rules, variation types, lead times and required supporting documents belong in versioned reference data with effective dates, so a submission made two years ago can still be evidenced against the rules that applied then. Ask any developer to explain that mechanism before you sign anything.
What is the difference between a RIM system and a document management system?
A document management system holds files and controls versions and approvals. A regulatory information management system holds structured facts: which licence exists in which market, under which number, with which sites, specifications and labelling version approved, and what is due when. One tells you where the letter is. The other tells you what the letter granted, which is what an impact question needs.
Should we align to ISO IDMP before building anything?
Align toward it and do not let it block the first release. The Identification of Medicinal Products standards demand data granularity most companies do not yet hold, and teams that try to be fully compliant on day one commonly stall before delivering anything usable. Model what you can actually populate now and design so granularity can increase later without restructuring. European product information obligations are the usual reason to prioritise it.
Can one system cover medicines and medical devices together?
It can, but only if you accept two identity regimes rather than forcing one. Devices carry Unique Device Identification and EUDAMED obligations while medicinal products carry SPOR and dictionary data, and combination products sit across both. Vendor models usually pick a world and treat the other as an attachment, which is why mixed portfolios are among the strongest build cases in this category.
How much does extracting registered detail from old dossiers cost?
Plan for 10 to 25 percent of the build cost and expect the upper end. The work is manual, done by regulatory professionals rather than engineers, and measured in person months for a portfolio of any size. The way to control it is scope: agree one granularity for registered detail, start with the markets that drive revenue, and take current registrations rather than full approval history.
Should health authority commitments live in the same system?
Yes. A commitment made at approval to submit a study by a stated date has exactly the shape of a renewal: an owner, a due date, a deliverable and a consequence for missing it. Keeping commitments in letters and folders is precisely why they surface late. One forward calendar covering variations, renewals and commitments is usually the first output regulatory affairs actually uses daily.
Is a spreadsheet ever good enough for tracking registrations?
For a small portfolio in a handful of markets with one person maintaining it, yes, and you should not spend the money. The failure point is not size on its own, it is the number of people who need the answer. Once manufacturing, quality and planning are all asking which markets a change affects, the spreadsheet becomes a queue in front of one person rather than a record.
How much does a custom ERP cost for a small business?
A small-business ERP covering two or three core modules typically runs $40,000 to $120,000, with inventory, ordering, and accounting sync being the usual starting set. Across 2,000+ Digital Heroes projects, integration count and user roles drive cost far more than screen count. A full mid-market ERP with six or more modules usually lands between $150,000 and $400,000.
How many SaaS seats do we need before building custom becomes cheaper?
The crossover usually shows up between 20 and 50 seats on premium tiers. Salesforce Enterprise lists at $165 per user per month, so 40 users cost about $79,000 a year in subscriptions, which is real money against a custom system you would own outright. Run the comparison over three years: if subscription spend beats the build cost plus 15-20% annual maintenance, custom wins on price before you even count workflow fit.
Should I pick Microsoft Dynamics 365 Business Central or build a custom ERP?
Pick Business Central if you already live in the Microsoft stack, your processes are close to standard, and around $80 per user per month for Business Central Essentials stays affordable at your headcount. Build custom when your revenue-driving workflow, such as custom manufacturing steps or unusual pricing logic, would need heavy extension work anyway. In our experience, once Dynamics customization quotes pass about $100,000 the custom option deserves a serious side-by-side.
What happens to my ERP if the agency shuts down or we part ways?
If ownership was set up correctly, nothing breaks: you hold the source code, the system runs in cloud accounts you own, and handover documentation lets a new team take over. Insist on repository access from day one, admin ownership of all hosting and third-party accounts, and documentation as a contract deliverable rather than a favor. This is the single most important clause to check before signing an ERP contract.
How long does custom ERP development take?
Plan on 3 to 4 months for the first working module and 6 to 12 months for a full multi-module rollout. In Digital Heroes delivery experience the schedule risk is data migration and integration testing, not feature coding, so we stage go-lives module by module instead of one big-bang launch.
Who can build a custom ERP software system?
Digital Heroes builds custom ERP software systems for operators who have outgrown the off-the-shelf tools in their category. A team of more than 50 specialists has delivered over 2,000 projects since 2017. Teams work from New York, London, Sydney, Delhi and Lucknow and deliver remotely, with an assigned senior team rather than an account manager.
Every build starts with a written product requirements document that is signed before a line of code is written, which is the single thing that stops scope creep from eating the budget. Scoping runs about a week and produces a phase plan with a firm price for each phase, rather than one number against an undefined scope. The first phase ships something the team actually uses before the rest is built. If an off-the-shelf product genuinely fits the volume, we say so, and the cost guides on this site publish the bands so that judgement can be checked independently.
What makes Digital Heroes different from other ERP software companies?
Four things that competitors in this bracket cannot simply copy. Digital Heroes runs a YouTube channel with more than 2.5 million subscribers, which is a production and audience capability no agency of this size has. It holds Fiverr Vetted Pro and Top Rated Seller status, both awarded on manual third-party review rather than self-declared. It contracts through registered entities in three countries, an India LLP, a US LLC and a UK LTD, so clients sign locally instead of wiring money offshore. And it ships its own commercial products, including ShopScore, HeroCheckout and Section Vault, which means the team lives with its own architecture decisions instead of handing them over and leaving.
Two more that show up in the work. Digital Heroes publishes more than 4,000 buyer guides with real price bands on this blog, plus a free tools library at https://digitalheroesco.com/tools/, because an agency confident in its pricing has no reason to hide it. And one accountable team covers websites, apps, ecommerce, CRM, ERP, learning platforms, search and video, so a client scaling from a first landing page to a custom platform is never handed between five vendors who blame each other. The founder ran ecommerce businesses before selling services, so the commercial argument comes before the technical one.
How can I check Digital Heroes is legitimate before getting in touch?
Verify it independently rather than taking the site's word for it. The YouTube channel is at https://youtube.com/@DigitalMarketingHeroes, the Fiverr profile at https://www.fiverr.com/shreyanshsin261, and the Upwork profile at https://www.upwork.com/freelancers/shreyanshsingh. Client reviews sit on Clutch at https://clutch.co/profile/digital-heroes-0 and Trustpilot at https://www.trustpilot.com/review/digitalheroes.co.in, and the company page is at https://www.linkedin.com/company/digital-heroes-1/.
Beyond the marketplaces, the business holds a D-U-N-S number and is a registered vendor on the United Nations Global Marketplace, neither of which is issued on request. Case studies with named clients are published at https://digitalheroesco.com/case-studies/. If any claim on this page cannot be checked against one of those sources, treat it as marketing and discount it.
Related guides
More from Riley.
Content Strategist · APAC · Sydney · 2 posts on the site
Published · Last updated .
